Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (131-140 of 364) with videos related to

Pageof 37
Sort By:
Oncoimmunology|March 14, 2024
Trial watch: dexmedetomidine in cancer therapyKillian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
Oncoimmunology|December 21, 2023
Trial watch: beta-blockers in cancer therapyKillian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2009
Defective autophagy control by the p53 rheostat in cancerLorenzo Galluzzi, Eugenia Morselli, Oliver Kepp, et al.
Cancers|December 7, 2019
Immunological Effects of Epigenetic ModifiersLucillia Bezu, Alejandra Wu Chuang, Peng Liu, et al.
Autophagy|November 7, 2019
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effectsOliver Kepp, Guo Chen, Didac Carmona-Gutierrez, et al.
Methods in Cell Biology|September 10, 2025
A protocol for measuring phenotypical facial disease markers in a mouse model of iatrogenic Cushing's syndromeHui Pan, Ai-Ling Tian, Isabelle Martins, et al.
Methods in Cell Biology|July 6, 2021
Autophagic flux assessment by immunoblotQi Wu, Ai-Ling Tian, Hui Pan, et al.
Oncoimmunology|June 3, 2022
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapyAdriana Petrazzuolo, M Chiara Maiuri, Laurence Zitvogel, et al.
Cellular and Molecular Life Sciences : CMLS|April 7, 2016
Regulated cell death and adaptive stress responsesLorenzo Galluzzi, José Manuel Bravo-San Pedro, Oliver Kepp, et al.
Journal of Translational Medicine|March 2, 2023
Immunogenic cell death in cancer: concept and therapeutic implicationsLorenzo Galluzzi, Oliver Kepp, Erik Hett, et al.
Pageof 37

Showing results (131-140 of 364) with videos related to

Sort By:
Pageof 37
Oncoimmunology|March 14, 2024
Trial watch: dexmedetomidine in cancer therapyKillian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
Oncoimmunology|December 21, 2023
Trial watch: beta-blockers in cancer therapyKillian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2009
Defective autophagy control by the p53 rheostat in cancerLorenzo Galluzzi, Eugenia Morselli, Oliver Kepp, et al.
Cancers|December 7, 2019
Immunological Effects of Epigenetic ModifiersLucillia Bezu, Alejandra Wu Chuang, Peng Liu, et al.
Autophagy|November 7, 2019
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effectsOliver Kepp, Guo Chen, Didac Carmona-Gutierrez, et al.
Methods in Cell Biology|September 10, 2025
A protocol for measuring phenotypical facial disease markers in a mouse model of iatrogenic Cushing's syndromeHui Pan, Ai-Ling Tian, Isabelle Martins, et al.
Methods in Cell Biology|July 6, 2021
Autophagic flux assessment by immunoblotQi Wu, Ai-Ling Tian, Hui Pan, et al.
Oncoimmunology|June 3, 2022
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapyAdriana Petrazzuolo, M Chiara Maiuri, Laurence Zitvogel, et al.
Cellular and Molecular Life Sciences : CMLS|April 7, 2016
Regulated cell death and adaptive stress responsesLorenzo Galluzzi, José Manuel Bravo-San Pedro, Oliver Kepp, et al.
Journal of Translational Medicine|March 2, 2023
Immunogenic cell death in cancer: concept and therapeutic implicationsLorenzo Galluzzi, Oliver Kepp, Erik Hett, et al.
Pageof 37